Is opportunistic disease prevention in the consultation ethically justifiable? by Getz, Linn et al.
doi:10.1136/bmj.327.7413.498 
 2003;327;498-500 BMJ
  
Linn Getz, Johann A Sigurdsson and Irene Hetlevik 
  
 consultation ethically justifiable?
Is opportunistic disease prevention in the
 http://bmj.com/cgi/content/full/327/7413/498
Updated information and services can be found at: 
 These include:
 References
 http://bmj.com/cgi/content/full/327/7413/498#otherarticles
10 online articles that cite this article can be accessed at: 
  
 http://bmj.com/cgi/content/full/327/7413/498#BIBL
This article cites 21 articles, 13 of which can be accessed free at: 
Rapid responses
 http://bmj.com/cgi/eletter-submit/327/7413/498
You can respond to this article at: 
  
 http://bmj.com/cgi/content/full/327/7413/498#responses
free at: 
3 rapid responses have been posted to this article, which you can access for
 service
Email alerting
box at the top left of the article 
Receive free email alerts when new articles cite this article - sign up in the
Topic collections
articles) 
 (446Patient - caregiver communication (including Patient education) 
 (1824 articles) Organization of health care 
 (362 articles) Other Medical Education 
 (684 articles) Clinical Research 
  
Articles on similar topics can be found in the following collections 
 Notes   
To order reprints follow the "Request Permissions" link in the navigation box 
 http://resources.bmj.com/bmj/subscribers
 go to: BMJTo subscribe to 
 on 30 December 2007 bmj.comDownloaded from 
Education and debate
Is opportunistic disease prevention in the consultation
ethically justifiable?
Linn Getz, Johann A Sigurdsson, Irene Hetlevik
Medical resources are increasingly shifting from making patients better to preventing them from
becoming ill. Genetic testing is likely to extend the list of conditions that can be screened for.
Is it time to stop and consider whom we screen and how we approach it?
Most medical experts and health authorities consider
consultations in primary health care ideal for
opportunistic health promotion and disease preven-
tion. Doctors are thus expected to discuss preventive
measures even when they are not among the reasons
for contact. But are such opportunistic initiatives
ethically justifiable in contemporary Western medi-
cine? We argue that doctors should maintain a clear
focus on each patient’s reasons for seeking help rather
than be distracted by an increasing list of standardised
preventive measures with unpredictable relevance to
the individual.
Aims of a good consultation
The cornerstone of medical practice is the consultation
between a patient who seeks help and a doctor whom
the person trusts.1 Several theoretical models have
been developed to analyse and improve the quality of
the consultation. In 1979, Stott and Davis presented an
influential model that elicited four potentials of the
encounter between patient and doctor: management
of presenting problems, modification of help seeking
behaviour, management of continuing problems, and
opportunistic health promotion.2 Since then, oppor-
tunistic preventive initiatives have become considered
to be part of good medical practice.
From a moral point of view, preventive medicine—
that is, initiatives to improve health among people who
are currently free of symptoms—is fundamentally
different from curative medicine, which is offered to
patients who seek medical help. The two disciplines
imply different promises and have different obligations
to the individuals whose lives they modify.3
Expanding agenda of risk and
prevention
When Stott and Davis developed their model, the
number of relevant opportunistic initiatives was
limited and seemed both technically feasible and ethi-
cally justifiable. However, interest in risk factors in
healthy populations has expanded rapidly over the
past two decades. A “risk epidemic” has occurred in
medical publishing,4 and the range of tests that can be
done or started in general practice has become exten-
sive. Discussion of lifestyle and monitoring blood pres-
sure of healthy people are well established. Other
indicators of cardiovascular risk have been added more
recently, including blood lipid concentrations, body
mass index, blood glucose concentration, and waist-hip
ratio. As authoritative researchers advocate lower
thresholds for intervention,5 6 asymptomatic people
are more likely to be labelled as at risk and needing
medical intervention and follow up.
The box gives the most common conditions for
which screening is encouraged in primary care.
Genetic tests that may help predict some common dis-
eases are likely to be included in the preventive arma-
mentarium before long. To maintain control of the
extensive preventive agenda, doctors are advised to
“build into their practice a system of reminders and
performance feedback to ensure necessary care.”7
The expansion of preventive biomedicine has
partly resulted from medical experts and other
stakeholders using aggressively assertive and presump-
tuous arguments.3 It is difficult to challenge the
benevolent mission of a preventive programme, andSU
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public health authorities have often welcomed such
initiatives with more enthusiasm than has been
warranted on scientific grounds.
Clinical inertia
In practice, doctors don’t always follow clinical
guidelines.7–10 This phenomenon has been designated
clinical inertia7 and is generally interpreted as a sign of
low quality care. Explanations include doctors overesti-
mating the quality of the care they actually provide, lack
of training, and use of soft excuses to avoid intervention.7
Lack of time is also a well known explanation. The pre-
ventive measures discussed here are rarely effective
enough to shift a large load of work away from treatment
of manifest disease in the practice population. The total
number of consultations will thus increase with the
introduction of each new screening routine. A recent
estimate shows that 7.4 hours of the working day of an
average primary care physician in the United States
would be needed to provide all services recommended
by the US Preventive Services Task Force.10
Problems of opportunistic screening
Other important but more subtle factors may also con-
tribute to doctors’ limited compliance with guidelines
on prevention. A clinician may hesitate to implement
preventive guidelines because of the challenges of
communicating risk.11 Most specialists in preventive
medicine show limited interest in the downsides of
preventive programmes and early intervention.3 12 The
individual’s decision about whether to participate
should, however, not be regarded as trivial.12 The
professional who offers a test carries a considerable
responsibility because informed consent presupposes
an understanding of the limitations of the pro-
gramme.13 Every test carries a chance of misclassifica-
tion of disease and false positive test results that lead to
further interventions that do not benefit the patient
and may cause harm.12 14 In addition, negative results
can give false reassurance.
Furthermore, patients and doctors tend to make
different choices depending on the way statistical esti-
mates of potential medical benefit are presented.11 12 15
A 55 year old man may, for instance, be quite interested
in an 18% reduction in the relative risk of dying from
colorectal cancer but more reluctant if told that screen-
ing implies an absolute risk reduction of only 0.014% a
year. He might alternatively consider that the
likelihood of not dying from colorectal cancer is
99.34% if you are screened and 99.20% if you are not
screened (numbers based on data in Kronborg et al16).
Unless the doctor is willing to solve this information
dilemma by using a simple paternalistic reminder such
as, “take the test, it is good for you,” many preventive
interventions seem too complex to suit Stott and
Davis’s “window of opportunity.”2
Another factor affecting clinical inertia may be the
applicability of research. Doctors who keep abreast of
scientific publishing are likely to become nihilistic when
reading that interventions which are effective in optimal
settings may be of marginal benefit in everyday practice
or even do more harm than good.17–19 Implementation
of preventive medical measures on a large scale is thus
not only becoming technically unmanageable, but a
matter of increasing ethical concern in relation to
individual patients.19
A final, decisive factor contributing to clinical inertia
may be the professional insight that health is affected by
factors other than those included in evidence based
biomedicine.1 20–23 Measurable pathophysiological dis-
turbances should not necessarily be interpreted as the
ultimate cause(s) of disease and suffering. External
factors, such as social inequality and destructive human
relations, greatly influence health and disease.1 21 23 A
focus on biotechnological interventions may divert the
dialogue between patient and doctor away from impor-
tant social and relational issues relevant to health.1 21 It is
not necessarily good medicine to focus on the manage-
ment of bodily risk factors in individuals who ask for
help to take control of their lives.
Patient autonomy in preventive medicine
The fall in professional autonomy and power of
individual doctors over the past few decades might be
expected to have resulted in increased patient
autonomy. The ongoing increase in centralised surveil-
lance and corporate power24 25 may, however, uninten-
tionally compromise patient autonomy and quality of
preventive care. As the list of accessible preventive tests
lengthens and thresholds for intervention are lowered,
a doctor who adheres to all recommendations for pro-
vision of preventive services may ultimately be able to
find something abnormal in everybody.
Relatively few empirical studies have examined the
effect of being labelled at risk. The results are
contradictory. The professional’s preconception is, of
course, that information about risk will increase
people’s sense of control over their lives and ultimately
their quality of life. But there is also a potential for risk
information to cast shadows of doubt and insecurity
over people’s lives, which means it may undermine
their experience of integrity and health. 8 20
The concept of patient autonomy should be
re-examined in light of the rapid expansion of
preventive biomedicine.19 26 It obviously embraces a per-
son’s freedom to consider, choose, or reject preventive or
therapeutic options after receiving sufficient infor-
mation. Once information about medical risk has been
passed on to a person, however, it cannot be retracted.
Respect for autonomy should therefore also honour the
person’s right not to be opportunistically confronted
with knowledge about biomedical risks that are
unrelated to his or her reasons for seeing the doctor.20
Conditions screened for in primary care
Hypertension
Coronary heart disease
Obesity
Hypercholesterolaemia
Diabetes
Breast cancer
Colorectal cancer
Cervical cancer
Chlamydia
Osteoporosis
Depression
Dementia
Alcohol misuse
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Future consultations
Clinical inertia in implementation of preventive medi-
cal guidelines should not necessarily be taken as a sign
of low quality care. It is time to reconsider the extent to
which specific, opportunistic initiatives to prevent
disease among asymptomatic individuals should
remain a core element of everyday consultations in
Western medicine. It is certainly good medical practice
to identify, emphasise, and support health promoting
resources,27 skills, and activities that have a logical link
to the patient’s reason for coming to see the doctor.
Other opportunistic initiatives may also seem appro-
priate. Doctors could increase patient autonomy by
inviting the patient to introduce a topic rather than
using a computerised reminding system. An open
ended invitation may be one way to proceed. For
example, “It could be that you have been considering
other things that might be good for your health? If
there is something you would like to discuss, you are
welcome.”
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Summary points
Opportunistic disease prevention and health
promotion are regarded as part of good primary
health care
The number of relevant preventive measures has
increased greatly over the past two decades
Decisions about preventive measures need proper
discussion about both benefits and harms, which
takes time
An extensive preventive agenda may divert the
dialogue between patient and doctor away from
important social and relational issues relevant to
the patient’s health
Routine opportunistic preventive initiatives may
no longer be ethically justifiable in contemporary
Western medicine
Corrections and clarifications
Why do children have chronic abdominal pain, and what happens to them when
they grow up? Population based cohort study
An error we made five years ago has just surfaced. In this article by
Matthew Hotopf and colleagues (BMJ 1998;316:1196-2000), we got a
number wrong in the Results section. The final sentence of the first
paragraph should start: “Of the risk set, 52 [not 32] were followed up to
the age of 36 years.”
Sexual health
We muddled the start of the “services” section of the summary box in
this editorial by Michael Adler (12 July, pp 62-3). The first two bullet
points should have been combined and have read: “Urgent review of
staffing requirements and an increase in the number of consultant
posts.”
Rhabdomyolysis
In converting to BMJ style the widely used term “9/11” in this editorial
by Russell Lane and Malcolm Phillips (19 July, pp 115-6), we
inadvertently referred to the attacks on the World Trade Center in New
York as taking place on 9 September 2001. The attacks took place, as we
all know, on 11 September.
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